Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 58 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
CD52
💬1. CD52
| - | Alemtuzumab
Alemtuzumab
💬1. CD52
| Alemtuzumab | [22] 13 13, 15, 19, 20, 36, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 💬1. CD52
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
TNFSF13B
💬2. TNFSF13B
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis [4] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Belimumab
Belimumab
💬2. TNFSF13B
| Belimumab | [13] 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬2. TNFSF13B
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
CYSLTR1
💬3. CYSLTR1
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction | Montelukast
Montelukast
💬3. CYSLTR1
| Montelukast | [8] 6 6, 13, 46, 61, 63, 85, 98, 228 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
PDE10A
💬4. PDE10A
| [4] Purine metabolism Purine metabolism, Metabolic pathways, cAMP signaling pathway, Morphine addiction | Aminophylline
Aminophylline
💬4. PDE10A
| Aminophylline | [1] 63 63 💬4. PDE10A
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
TNFRSF13C
💬5. TNFRSF13C
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Human T-cell leukemia virus 1 infection, Primary immunodeficiency [5] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Ianalumab
Ianalumab
💬5. TNFRSF13C
| Ianalumab | [7] 35 35, 46, 49, 53, 61, 63, 95 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
ADORA1
💬6. ADORA1
| [7] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction [7] cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ... | Aminophylline
Aminophylline
💬6. ADORA1
| Aminophylline | [1] 63 63 💬6. ADORA1
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
ADORA2B
💬7. ADORA2B
| [5] Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Alcoholism [5] Rap1 signaling pathway, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vasc ... | Aminophylline
Aminophylline
💬7. ADORA2B
| Aminophylline | [1] 63 63 💬7. ADORA2B
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
DNMT1
💬8. DNMT1
| [3] Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer | Decitabine
Decitabine
💬8. DNMT1
| Decitabine | [3] 13 13, 60, 63 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
DNMT3A
💬9. DNMT3A
| [3] Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer | Decitabine
Decitabine
💬9. DNMT3A
| Decitabine | [3] 13 13, 60, 63 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
DNMT3B
💬10. DNMT3B
| [3] Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer | Decitabine
Decitabine
💬10. DNMT3B
| Decitabine | [3] 13 13, 60, 63 💬
|